Bladder Stone
ICD-10 N21.0 · ICD-11 GB71.0

Treating Radiolucent or Known Uric Acid Bladder Stones in Adults

Clinical Scenario

This protocol applies to adults who have a radiolucent bladder stone identified on plain X-ray, or a bladder stone confirmed or strongly suspected to be of uric acid composition. In this group, the non-surgical, oral route is the recommended first-line approach before procedural intervention is considered.

Treatment Approach

The cornerstone of management is oral chemolitholysis — a non-invasive dissolution strategy — supported by regular urine pH monitoring. The specific agents, target pH threshold, titration schedule, and follow-up imaging regimen are detailed in the full protocol.

Full regimen, dosing guidance, and monitoring intervals available in the structured protocol below.

Treatment Goals
Instant Access to Structured Evidence-Based Regimens
References
  1. Offer oral chemolitholysis for radiolucent or known uric acid bladder stones in adults.
  2. Uric acid stones can be dissolved by oral urinary alkalinisation when a pH > 6.5 is consistently achieved, typically using an alkaline citrate or sodium bicarbonate.
  3. Use an alkaline citrate or sodium bicarbonate with frequent urine pH monitoring and dose titration to achieve a consistent pH > 6.5.
View source ↗